scholarly journals Early-stage breast cancer and employment participation after 2 years of follow-up: A comparison with age-matched controls

Cancer ◽  
2018 ◽  
Vol 124 (9) ◽  
pp. 2026-2035 ◽  
Author(s):  
Christine C. Ekenga ◽  
Maria Pérez ◽  
Julie A. Margenthaler ◽  
Donna B. Jeffe
Keyword(s):  
Breast Cancer ◽  
Early Stage ◽  
Early Stage Breast Cancer ◽  
Employment Participation

scholarly journals Augmented expression of Polo-like kinase 1 is a strong predictor of shorter cancer-specific overall survival in early stage breast cancer at 15-year follow-up

2016 ◽  
Vol 12 (3) ◽  
pp. 1667-1674 ◽  
Author(s):  
Piotr Donizy ◽  
Agnieszka Halon ◽  
Pawel Surowiak ◽  
Maciej Kaczorowski ◽  
Cyprian Kozyra ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Overall Survival ◽  
Early Stage ◽  
Strong Predictor ◽  
Early Stage Breast Cancer

7 Poster IORT AS ANTICIPATED BOOST IN EARLY STAGE BREAST CANCER: TEN YEARS FOLLOW UP AT S. FILIPPO NERI HOSPITAL IN ROME

2011 ◽  
Vol 99 ◽  
pp. S6-S7
Author(s):  
A. Ciaballoni ◽  
M.A. Mirri ◽  
V. Ciccone ◽  
T. Palloni ◽  
F. Vidiri ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Early Stage ◽  
Early Stage Breast Cancer

scholarly journals Discharge to Primary Care for Survivorship Follow-Up: How Are Patients With Early-Stage Breast Cancer Faring?

2015 ◽  
Vol 13 (6) ◽  
pp. 762-771 ◽  
Author(s):  
Cindy Railton ◽  
Sasha Lupichuk ◽  
Jennifer McCormick ◽  
Lihong Zhong ◽  
Jenny Jaeeun Ko ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Primary Care ◽  
Early Stage ◽  
Early Stage Breast Cancer

Use of diagnostic testing for patients with early-stage breast cancer in a multi-hospital quality collaborative in Michigan.

2012 ◽  
Vol 30 (34_suppl) ◽  
pp. 242-242
Author(s):  
Tara M. Breslin ◽  
James Kubus ◽  
Haythem Y. Ali ◽  
T. Trevor Singh ◽  
Paul T. Adams ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Diagnostic Imaging ◽  
Early Stage ◽  
Diagnostic Testing ◽  
Early Stage Breast Cancer ◽  
Comprehensive Cancer Center ◽  
Cancer Center ◽  
Positron Emission ◽  
Bone Scans

242 Background: In 2012, ASCO identified five opportunities to improve the quality of cancer care and reduce costs. Two of these recommendations focused on limiting use of advanced diagnostic imaging with computed tomography (CT), Positron Emission Tomography (PET), and radionuclide bone scans (BS) at diagnosis and during surveillance for women with early stage breast cancer with a low risk of metastasis. We describe the use of diagnostic imaging among patients with early stage breast cancer treated at hospitals in Michigan. Methods: The Michigan Breast Oncology Quality Initiative is a collaboration between Michigan hospitals, the University of Michigan Comprehensive Cancer Center, and the National Comprehensive Cancer Network (NCCN). This collaborative collects longitudinal demographic, staging, treatment, and follow up data using the NCCN Breast Outcomes Database platform. We analyzed use of advanced diagnostic testing with CT, PET, BS and contrast it with use of traditional imaging (mammography/ultrasound) at diagnosis and during follow up in patients with stage 0, I, II breast cancer between 1998 to 2009. Patients who died or recurred were excluded. Results: The cohort included 7,632 patients (19.6% stage 0, 48.1% stage I, 32.3% stage II) treated at 17 hospitals. Use of traditional imaging was documented in nearly 100% of patients at diagnosis and throughout the follow up period. With respect to advanced diagnostic imaging, 20.3 % underwent CT, 4.7% underwent PET, and 11.6% underwent BS at diagnosis. Advanced testing use decreased over time (Table). Conclusions: Despite published guidelines, which recommend against their routine use, advanced diagnostic imaging use was prevalent among patients treated for early breast cancer at MiBOQI hospitals. Education efforts should target physicians and patients on the lack of proven benefit and potential risks of using advanced diagnostic imaging in this population. [Table: see text]

Sign in / Sign up

Export Citation Format

Share Document